
Aimee J. Li
Supervisory Patent Examiner (ID: 15085, Phone: (571)272-4169 , Office: P/2183 )
| Most Active Art Unit | 2183 |
| Art Unit(s) | 2137, 2100, 2183, 2195 |
| Total Applications | 539 |
| Issued Applications | 378 |
| Pending Applications | 21 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18537884
[patent_doc_number] => 20230242987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHODS AND KITS FOR EVALUATING THE RISK OF DISEASES OR CONDITIONS ASSOCIATED WITH ATHEROSCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 17/945832
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945832
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945832 | METHODS AND KITS FOR EVALUATING THE RISK OF DISEASES OR CONDITIONS ASSOCIATED WITH ATHEROSCLEROSIS | Sep 14, 2022 | Abandoned |
Array
(
[id] => 19051307
[patent_doc_number] => 20240093276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SYSTEM AND METHOD FOR TISSUE-WIDE SINGLE CELL POST-TRANSCRIPTIONAL PROFILING OF MULTIPLE MOLECULAR TARGETS
[patent_app_type] => utility
[patent_app_number] => 17/931942
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931942 | SYSTEM AND METHOD FOR TISSUE-WIDE SINGLE CELL POST-TRANSCRIPTIONAL PROFILING OF MULTIPLE MOLECULAR TARGETS | Sep 13, 2022 | Pending |
Array
(
[id] => 18350461
[patent_doc_number] => 20230138572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER
[patent_app_type] => utility
[patent_app_number] => 17/822720
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822720 | METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER | Aug 25, 2022 | Abandoned |
Array
(
[id] => 18065755
[patent_doc_number] => 20220396842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/820987
[patent_app_country] => US
[patent_app_date] => 2022-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820987 | METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER | Aug 18, 2022 | Abandoned |
Array
(
[id] => 18666578
[patent_doc_number] => 11773456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Loop-mediated isothermal amplification (LAMP) primer sets for detecting porcine susceptibility-related pathogenic bacteria, and kit, LAMP chip and use based on the same
[patent_app_type] => utility
[patent_app_number] => 17/820601
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 7293
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 575
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820601 | Loop-mediated isothermal amplification (LAMP) primer sets for detecting porcine susceptibility-related pathogenic bacteria, and kit, LAMP chip and use based on the same | Aug 17, 2022 | Issued |
Array
(
[id] => 18511727
[patent_doc_number] => 20230227914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => BIOMARKERS OF ORAL, PHARYNGEAL AND LARYNGEAL CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/888290
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888290 | BIOMARKERS OF ORAL, PHARYNGEAL AND LARYNGEAL CANCERS | Aug 14, 2022 | Abandoned |
Array
(
[id] => 19512453
[patent_doc_number] => 20240344139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTION OF COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 18/580444
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/580444 | COMPOSITIONS AND METHODS FOR DETECTION OF COLORECTAL CANCER | Jul 20, 2022 | Pending |
Array
(
[id] => 19480990
[patent_doc_number] => 20240329032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => METHODS OF DIFFERENTIATING NEURAL CELLS AND PREDICTING ENGRAFTMENT THEREOF AND RELATED COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/580557
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -91
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/580557 | METHODS OF DIFFERENTIATING NEURAL CELLS AND PREDICTING ENGRAFTMENT THEREOF AND RELATED COMPOSITIONS | Jul 19, 2022 | Pending |
Array
(
[id] => 18093514
[patent_doc_number] => 20220411855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => PORTABLE, LOW-COST PATHOGEN DETECTION AND STRAIN IDENTIFICATION PLATFORM
[patent_app_type] => utility
[patent_app_number] => 17/849250
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849250
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/849250 | Portable, low-cost pathogen detection and strain identification platform | Jun 23, 2022 | Issued |
Array
(
[id] => 19210954
[patent_doc_number] => 12000004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Methods for molecularly characterizing cervical cell samples
[patent_app_type] => utility
[patent_app_number] => 17/839803
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 12693
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839803 | Methods for molecularly characterizing cervical cell samples | Jun 13, 2022 | Issued |
Array
(
[id] => 17883079
[patent_doc_number] => 20220298556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PIRNA-54265 DETECTION KIT USED FOR EARLY SCREENING, DIAGNOSIS, CURATIVE EFFICACY MONITORING AND PROGNOSTIC EVALUATION OF COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 17/830354
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830354 | PIRNA-54265 detection kit used for early screening, diagnosis, curative efficacy monitoring and prognostic evaluation of colorectal cancer | Jun 1, 2022 | Issued |
Array
(
[id] => 19361181
[patent_doc_number] => 20240263215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => ASSAYS
[patent_app_type] => utility
[patent_app_number] => 18/564698
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564698
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564698 | ASSAYS | May 26, 2022 | Pending |
Array
(
[id] => 17838158
[patent_doc_number] => 20220275463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => STRATIFICATION AND PROGNOSIS OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/751038
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751038 | STRATIFICATION AND PROGNOSIS OF CANCER | May 22, 2022 | Abandoned |
Array
(
[id] => 18909267
[patent_doc_number] => 11872230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Method of treating a methionine-dependent cancer
[patent_app_type] => utility
[patent_app_number] => 17/745292
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 22701
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745292
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745292 | Method of treating a methionine-dependent cancer | May 15, 2022 | Issued |
Array
(
[id] => 19345593
[patent_doc_number] => 20240254556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => NOVEL PREDICTIVE BIOMARKERS FOR SECONDARY AUTOIMMUNITY AFTER LYMPHOCYTE DEPLETING THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/560569
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560569
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/560569 | NOVEL PREDICTIVE BIOMARKERS FOR SECONDARY AUTOIMMUNITY AFTER LYMPHOCYTE DEPLETING THERAPY | May 12, 2022 | Pending |
Array
(
[id] => 17838929
[patent_doc_number] => 20220276234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/739731
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739731 | POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION | May 8, 2022 | Pending |
Array
(
[id] => 17990484
[patent_doc_number] => 20220356521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS FOR DETECTING, MONITORING, AND GUIDING TREATMENT OF ALLOGRAFT REJECTION USING DISCRIMINATING GENE EXPRESSION SIGNATURES
[patent_app_type] => utility
[patent_app_number] => 17/733762
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/733762 | METHODS FOR DETECTING, MONITORING, AND GUIDING TREATMENT OF ALLOGRAFT REJECTION USING DISCRIMINATING GENE EXPRESSION SIGNATURES | Apr 28, 2022 | Pending |
Array
(
[id] => 18764301
[patent_doc_number] => 11814688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Markers for determining tumor hypoxia
[patent_app_type] => utility
[patent_app_number] => 17/728506
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 15
[patent_no_of_words] => 19739
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728506 | Markers for determining tumor hypoxia | Apr 24, 2022 | Issued |
Array
(
[id] => 17990493
[patent_doc_number] => 20220356530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS FOR DETERMINING VELOCITY OF TUMOR GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/725341
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725341 | METHODS FOR DETERMINING VELOCITY OF TUMOR GROWTH | Apr 19, 2022 | Pending |
Array
(
[id] => 17830558
[patent_doc_number] => 20220267862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => DNA METHYLATION SIGNATURES OF CANCER IN HOST PERIPHERAL BLOOD MONONUCLEAR CELLS AND T CELLS
[patent_app_type] => utility
[patent_app_number] => 17/700702
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 416
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700702 | DNA METHYLATION SIGNATURES OF CANCER IN HOST PERIPHERAL BLOOD MONONUCLEAR CELLS AND T CELLS | Mar 21, 2022 | Pending |